C

Caladrius Biosciences Inc
LSE:0HS8

Watchlist Manager
Caladrius Biosciences Inc
LSE:0HS8
Watchlist
Price: 2.58 USD -5.15% Market Closed
Market Cap: 50m USD
Have any thoughts about
Caladrius Biosciences Inc?
Write Note

Wall Street
Price Targets

0HS8 Price Targets Summary
Caladrius Biosciences Inc

Wall Street analysts forecast 0HS8 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0HS8 is 14.35 USD with a low forecast of 13.19 USD and a high forecast of 15.82 USD.

Lowest
Price Target
13.19 USD
411% Upside
Average
Price Target
14.35 USD
456% Upside
Highest
Price Target
15.82 USD
513% Upside
Caladrius Biosciences Inc Competitors:
Price Targets
TNG
Transgene SA
326% Upside
ELDN
Eledon Pharmaceuticals Inc
192% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
26% Upside
4587
PeptiDream Inc
36% Upside
OXB
Oxford BioMedica PLC
29% Upside
358570
GI Innovation Inc
202% Upside
688363
Bloomage Biotechnology Corp Ltd
4% Upside
300685
Amoy Diagnostics Co Ltd
30% Upside

Revenue
Forecast

Revenue Estimate
Caladrius Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Caladrius Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Caladrius Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-92%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 0HS8's stock price target?
Price Target
14.35 USD

According to Wall Street analysts, the average 1-year price target for 0HS8 is 14.35 USD with a low forecast of 13.19 USD and a high forecast of 15.82 USD.

Back to Top